Back to Newsroom

StemCells, Inc. Announces New Preclinical Data Showing HuCNS-SC(R) Cells Preserve Visual Function by Keeping Photoreceptors Normal and Healthy

NEWARK, Calif., (September 18, 2013) – StemCells, Inc. (Nasdaq: STEM) today announced the publication of preclinical data confirming that the Company’s proprietary HuCNS-SC cells (purified human neural stem cells) preserve photoreceptor cells and visual function in a widely used model of retinal degeneration.